Federal contract award

75N95020F00002

CHARACTERIZATION OF A NON-ADDICTIVE SMALL MOLECULE THERAPEUTICS FOR THE MANAGEMENT OF NON-CANCER PAIN PERIOD OF PERFORMANCE SEPTEMBER 18, 2020 - SEPTEMBER 17, 2022

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNATIONAL INSTITUTES OF HEALTH NIDA
NAICS541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSCAN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
Parent award / vehicle75N95019D00012
Set-asideNot reported
Pricing typeCOST PLUS FIXED FEE
Obligations$2.3M
Current contract value$2.3M
Potential contract value / ceiling$3.9M
Start dateSep 18, 2020
Current end dateApr 28, 2025
Potential end dateApr 28, 2025
Latest award activityApr 28, 2025
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 10 of 10 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Apr 28, 2025P00009$0EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI NOTICE OF TERMINATION FOR CONVENIENCE CHARACTERIZATION OF A NON-ADDICTIVE SMALL MOLECULE THERAPEUTICS FOR THE MANAGEMENT OF NON-CAN
Dec 17, 2024P00008$0CHARACTERIZATION OF A NON-ADDICTIVE SMALL MOLECULE THERAPEUTICS FOR THE MANAGEMENT OF NON-CANCER PAIN.
Sep 17, 2024P00007$120.9KCHARACTERIZATION OF A NON-ADDICTIVE SMALL MOLECULE THERAPEUTICS FOR THE MANAGEMENT OF NON-CANCER PAIN.
Aug 25, 2023P00006$168.6KCHARACTERIZATION OF A NON-ADDICTIVE SMALL MOLECULE THERAPEUTICS FOR THE MANAGEMENT OF NON-CANCER PAIN.
Sep 23, 2022P00005$798.2KCHARACTERIZATION OF A NON-ADDICTIVE SMALL MOLECULE THERAPEUTICS FOR THE MANAGEMENT OF NON-CANCER PAIN.
Apr 6, 2022P00004$369.8KCHARACTERIZATION OF A NON-ADDICTIVE SMALL MOLECULE THERAPEUTICS FOR THE MANAGEMENT OF NON-CANCER PAIN.
Aug 30, 2021P00003$269.3KCHARACTERIZATION OF A NON-ADDICTIVE SMALL MOLECULE THERAPEUTICS FOR THE MANAGEMENT OF NON-CANCER PAIN. POP SEPT. 18, 2020 - SEPT. 17, 2022. MOD P00001: TO EXERCISE AN OPTION. MOD P00002: TO EXERCISE OPTIONS. MOD P00003: TO EXERCISE OPTION AND REMOVE
May 25, 2021P00002$223.6KCHARACTERIZATION OF A NON-ADDICTIVE SMALL MOLECULE THERAPEUTICS FOR THE MANAGEMENT OF NON-CANCER PAIN. POP SEPT. 18, 2020 - SEPT. 17, 2022. MOD P00001: TO EXERCISE AN OPTION. MOD P00002: TO EXERCISE OPTIONS.
Oct 30, 2020P00001$32.2KCHARACTERIZATION OF A NON-ADDICTIVE SMALL MOLECULE THERAPEUTICS FOR THE MANAGEMENT OF NON-CANCER PAIN; PERIOD OF PERFORMANCE SEPTEMBER 18, 2020 - SEPTEMBER 17, 2022. MODIFICATION P00001: TO EXERCISE AN OPTION FOR ADDITIONAL QUANTITIES.
Sep 15, 20200$344.6KCHARACTERIZATION OF A NON-ADDICTIVE SMALL MOLECULE THERAPEUTICS FOR THE MANAGEMENT OF NON-CANCER PAIN PERIOD OF PERFORMANCE SEPTEMBER 18, 2020 - SEPTEMBER 17, 2022

Research next steps

  1. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.